$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Enhabit Inc. (NYSE: EHAB) [Accessibility Statement] Skip NavigationNEW YORK, Feb. 24, 2026 /PRNewswire/ -- Class Action Attorney [Juan Monteverde] with [Monteverde & Associates PC](the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is inve ...

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - February 24, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Enhabit, Inc. ("Enhabit" or the "Company") (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Kinderhook Industries, LLC ("Kinderhook") for $13.80 a share in an all-cash transaction for a total enterprise value of approximately $1.1 bi ...

UBS sets a price target of $13.80 for NYSE:EHAB, indicating a potential increase of about 1.47%.The proposed sale to Kinderhook Industries, LLC aligns with UBS's price target, suggesting market anticipation of the sale price.EHAB's stock price has surged by 22.63%, reflecting investor optimism towards the proposed sale.Enhabit, Inc. (NYSE:EHAB) is currently under the spotlight due to a proposed sale to Kinderhook Industries, LLC. UBS has set a price target of $13.80 for EHAB, which is slightly above its cur ...

UBS downgraded Enhabit, Inc. (NYSE: EHAB) to Neutral from Hold as the company enters a definitive acquisition agreement with Kinderhook Industries.Enhabit stockholders to receive $13.80 per share in cash, reflecting a premium over the current stock price of $13.60.The stock has seen a significant increase of 22.63%, with a year-high price of $13.64, amidst investor optimism regarding the acquisition.Enhabit, Inc. (NYSE: EHAB) is a leading provider of home health and hospice services in the United States. Th ...

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nyse-ehab/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. CONNECT WITH US: Facebook ...

EHAB Stock Alert: Halper Sadeh LLC is Investigating Whether Enhabit, Inc. is Obtaining a Fair Price for its Shareholders-# EHAB Stock Alert: Halper Sadeh LLC is Investigating Whether Enhabit, Inc. is Obtaining a Fair Price for its ShareholdersShare---Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.The proposed transaction may contain terms that could limit superior competing offers.Shareholders are encouraged to contact the firm to discuss their rights and ...

Shareholder Alert: The Ademi Firm investigates whether Enhabit Inc. is obtaining a Fair Price for its Public Shareholders [Accessibility Statement] Skip NavigationMILWAUKEE, Feb. 23, 2026 /PRNewswire/ -- Ademi LLP is investigating Enhabit (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Kinderhook Industries.Click [here] to learn how to join our investigation and obtain additional information or contact us at [[email protected]] or t ...

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead ...

Core Insights - Enhabit, Inc. and Encompass Health Corporation have successfully collected $43.1 million in full satisfaction of their claims for attorneys' fees and mitigation damages [1] Legal Proceedings - The claims were filed in the Delaware Court of Chancery against former officer Chris Walker, Vistria Group senior partner David Schuppan, and Nautic Partners managing director Christopher Corey [1] - These claims are related to a December 2024 judgment that favored Enhabit and Encompass [1]

Industry Overview - The Medical Services sector is rapidly evolving due to digital health advancements, value-based care adoption, and a focus on patient-centric solutions [1] - The global healthcare analytics market is projected to grow from $56.64 billion in 2025 at a CAGR of 22.7% through 2035, benefiting payers, providers, and analytics vendors [1] - The industry includes various service providers such as pharmacy benefit managers, contract research organizations, and healthcare workforce solution providers, transitioning from volume-based to value-based care [3] Key Trends - The U.S. digital health market is expected to grow from $92.08 billion in 2025 to $248.11 billion by 2034, with a CAGR of 11.6% [4] - The global big data in healthcare market is valued at $110.97 billion in 2025, projected to grow at a CAGR of 19.2% from 2026 to 2035 [4] - Companies adopting AI technologies have seen a 50% reduction in treatment costs and over 50% improvement in patient outcomes [4] Workforce Challenges - A projected healthcare worker shortage of 100,000 by 2028, including a shortfall of 73,000 nursing assistants, is expected to elevate labor costs [2][5] - The WHO estimates a shortfall of 11 million physicians, particularly in low-income countries, emphasizing the need for workforce expansion [5] - Total hospital expenses increased by 5.1% in 2024, significantly outpacing the overall inflation rate of 2.9% [5] Company Highlights - **Medpace Holdings (MEDP)**: Expected earnings growth rate of 17.2% in 2025, with revenues projected to rise by 18.7% from 2024 [19][20] - **Enhabit, Inc. (EHAB)**: Anticipated earnings surge of 161.9% in 2025, with revenue growth of 2.3% [23][24] - **Progyny (PGNY)**: Projected earnings increase of 9.8% in 2025, with revenues expected to grow by 9.2% [26][27] Performance Metrics - The Medical Services industry has gained 6.8% over the past year, in line with the Medical sector, but lagged behind the S&P 500's 19.3% increase [10] - The industry is currently trading at a forward P/E of 16.9X, compared to the S&P 500's 23.3X and the sector's 21.6X [14]